Financials data is unavailable for this security.
View more
Year on year Beijing Chunlizhengda Medical Instruments Co Ltd 's net income fell -9.72% from 307.72m to 277.82m despite flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 25.09% to 29.24%.
| Gross margin | 71.08% |
|---|---|
| Net profit margin | 17.12% |
| Operating margin | 18.98% |
| Return on assets | 4.62% |
|---|---|
| Return on equity | 5.68% |
| Return on investment | 5.49% |
More ▼
Cash flow in CNYView more
In 2023, Beijing Chunlizhengda Medical Instruments Co Ltd increased its cash reserves by 32.26%, or 308.82m. The company earned 511.71m from its operations for a Cash Flow Margin of 42.34%. In addition the company used 81.56m on investing activities and also paid 121.33m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 7.29 |
|---|---|
| Tangible book value per share | 6.91 |
More ▼
Balance sheet in CNYView more
| Current ratio | 4.76 |
|---|---|
| Quick ratio | 3.80 |
| Total debt/total equity | 0.0003 |
|---|---|
| Total debt/total capital | 0.0003 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share increased 15.65% while earnings per share excluding extraordinary items fell by -7.69%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 87.69% |
| EPS growth(5 years) | 18.66 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -41.77 |
More ▼
